The table below shows Merck & Co., Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$3.92B
$2.50B
$3.09B
$1.34B
$4.76B
$1.79B
Capital expenditure
$991.00M
$1.33B
$861.00M
$1.01B
-
-
Investing cash flow
-$10.21B
-$1.49B
-$1.38B
-$2.36B
-$1.17B
-$738.00M
Dividends paid
$2.10B
$2.05B
$1.95B
$1.85B
MRK operating cash flow (10-K history)
Merck & Co., Inc. reported operating cash flow of $16.47B for fiscal year 2025. That is down 23.3% from $21.47B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $12.54B (FY 2015) to $16.47B. Figures come from the company's audited annual reports as filed with the SEC.
